Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach
DOI10.2202/1544-6115.1341zbMATH Open1276.62073OpenAlexW2138454055WikidataQ31148226 ScholiaQ31148226MaRDI QIDQ2864014FDOQ2864014
Authors: A. Geert Heidema, Nico Nagelkerke 
Publication date: 5 December 2013
Published in: Statistical Applications in Genetics and Molecular Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2202/1544-6115.1341
Recommendations
- Breast cancer diagnosis from proteomic mass spectrometry data: a comparative evaluation
- Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples
- Reproducibility of biomarker identifications from mass spectrometry proteomic data in cancer studies
- Classification of breast cancer versus normal samples from mass spectrometry profiles using linear discriminant analysis of important features selected by random forest
- A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry
- A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection
- Predicting patient survival from proteomic profile using mass spectrometry data: an empirical study
- Feature selection and machine learning with mass spectrometry data for distinguishing cancer and non-cancer samples
- Detection of cancer-specific markers amid massive mass spectral data
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)
Cited In (3)
This page was built for publication: Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2864014)
